SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024434
Filing Date
2022-11-10
Accepted
2022-11-10 16:02:35
Documents
68
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q aldx-20220930.htm   iXBRL 10-Q 2517212
2 EX-31.1 aldx-ex31_1.htm EX-31.1 19086
3 EX-31.2 aldx-ex31_2.htm EX-31.2 19513
4 EX-32.1 aldx-ex32_1.htm EX-32.1 16583
  Complete submission text file 0000950170-22-024434.txt   7630886

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aldx-20220930.xsd EX-101.SCH 44254
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aldx-20220930_lab.xml EX-101.LAB 361889
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aldx-20220930_def.xml EX-101.DEF 138182
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT aldx-20220930_cal.xml EX-101.CAL 42176
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aldx-20220930_pre.xml EX-101.PRE 263835
62 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20220930_htm.xml XML 1283154
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36332 | Film No.: 221376937
SIC: 2834 Pharmaceutical Preparations